Reasons for clinical ineligibility to participate by site (proportion of total ineligible (%)).

<p>Reasons for clinical ineligibility to participate by site (proportion of total ineligible (%)).</p

HINTS Study Sites.

<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0039530#pone.0039530-Health1" target="_blank">[1]</a> Health Protection Agency. HIV in the United Kingdom 2010. Health Protection Agency; 2010 [accessed 24th January 2011]; Available from: <a href="http://www.hpa.org.uk/Publications/InfectiousDiseases/HIVAndSTIs/1011HIVUK2010Report/" target="_blank">http://www.hpa.org.uk/Publications/InfectiousDiseases/HIVAndSTIs/1011HIVUK2010Report/</a>.</p

Multivariable logistic regression model showing potential predictors of HIV test uptake in patients who completed the questionnaire.

<p> <i>(n = 1003; adjusted for age, ethnicity and other variables in the model, and stratified by site; MSM = men who have sex with men).</i></p

Coverage, uptake and seropositivity of routine offer of HIV test across the four sites.

<p>Coverage, uptake and seropositivity of routine offer of HIV test across the four sites.</p

Multivariable logistic regression model showing significant independent predictors of HIV test uptake in patients who were offered the test.

<p> <i>(n = 6194; adjusted for ethnicity, and other variables in the model, and stratified by site).</i></p

Staff attitudes and barriers to the provision of HIV tests in non-specialist settings.

<p>Staff attitudes and barriers to the provision of HIV tests in non-specialist settings.</p

Prevalence of HIV-positive test by ethnicity and region.

<p>Prevalence of HIV-positive test by ethnicity and region.</p

Prevalence of HIV by indicator condition.

*<p>Unpublished prevalence data from participating study sites.</p>**<p>includes MSM, IDU prevalence.</p>***<p>UNAIDS adults aged 15–49 country HIV prevalence rate <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0052845#pone.0052845-UNAIDS2" target="_blank">[31]</a>.</p

Patient characteristics by European region.

1<p>North:Denmark, Sweden, Netherlands, UK, West Central: Austria, Belgium, Germany, East Central: Belarus, Bosnia, Croatia, Poland, Ukraine and South: Italy and Spain.</p>2<p>IQR:Interquartile range.</p>3<p>STI: Sexually transmitted infection, LYM: Malignant lymphoma, CAN: Cervical or anal cancer/dysplasia, HZV: Herpes zoster, HEP: Hepatitis B or C, MON: Ongoing mononucleosis-like illness, CYT: Unexplained leukocytopenia/thrombocytopenia lasting >4 weeks, SEB: Seborrheic dermatitis/exanthema (SEB).</p><p>Missing data: 10 (0.3%) gender, 120 (3.3%) ethnicity, 63 (1.8%) age, 120 (3.3%) sexual orientation, 291 (8.1%) previous HIV test.</p